News & Events

Filter Events by

February 12, 2024

news

We are exited to announce that HTuO has joined Johnson & Johnson Innovation JLABS in San Francisco. For more information, please read the press release.

February 2, 2024

newsevent

HTuO Biosciences will be attending the 2024 OBIO Investment Summit in Toronto, February 14-16, 2024. Our CEO, Dr. Anthony Fejes, will present an update on HTuO on February 16 in the morning session.

December 13, 2023

newsevent

HTuO Biosciences will be attending the Biotech Showcase in San Francisco during the JPM-week, January 8-10, 2024. We’ll be presenting our newest data on Monday, January 4 from 4:15 - 4:30pm PST in Franciscan B.

November 30, 2023

news

We have exciting news to share at HTuO Biosciences. We are pleased to announce the addition of the Director of Technology to our leadership team. Jason Loscher joins HTuO and will take ownership of the build, implementation, and management of the development strategy for the core computational technology.

November 1, 2023

newsevent

HTuO Biosciences will be attending Canada in the Valley Showcase, Nov. 15th & 16th, presented by CELS accelerator (Canadian Entrepreneurs in Life Science), in San Francisco. The goal of the showcase is to connect with investors, industry leaders and strategic partners in the Bay Area.

October 26, 2023

newsevent

HTuO Biosciences will be presenting at Life Science BC’s Invest in BC, presented by Lumira Ventures, on November 2, 2023. Find us in session 4, where our CEO, Dr. Anthony Fejes, will be sharing our progress and exciting future opportunities.

Jun 28, 2023

newsevent

HTuO Biosciences’ poster has been selected for the COMP Sci-Mix poster session at the ACS Fall Meeting on August 14th, representing exceptional submissions accepted by the participating division. The poster will also be at the COMP division session at ACS on August 15th from 7-9 p.m.

May 19, 2023

newsevent

HTuO Biosciences’ poster - AtomForge: A novel polarizable and reactive force field for commercial scale applications - has been accepted at the American Chemical Society Meeting, August 13 - 17, 2023.

Apr 24, 2023

newsevent

Our CEO, Dr. Anthony Fejes, and Director of Business Development, Mr. Jacek Mis, will be in Boston, June 5-8 at the 2023 BIO International Convention. Connect with us through the partnering portal or email us directly to learn about our technology and its therapeutic potential.

January 17th, 2023

newsevent

We have just released our first white paper, which describes the development of our technology - “Proof of Concept of AtomForge: A Novel Polarizable and Reactive Force Field.” Please email us at info@htuobio.com if you want to read it.

Nov 4, 2022

newsevent

HTuO Biosciences will be presenting at Life Science BC’s Invest in the West, sponsored by Lumira Ventures. Find us in session 8, where our CEO, Dr. Anthony Fejes, will be presenting and participating in a live Q&A session hosted by LDV Partners.

Nov 2-4, 2022

newsevent

HTuO Biosciences will be attending the digital partnering component of BIO Europe 2022. If you are in the business of optimizing drugs, we would like to connect with you. Please find us through the partnering platform or email us directly at info@htuobio.com to schedule a meeting.

Jun 1, 2022

newsevent

HTuO’s CEO, Dr. Anthony Fejes, participated in a panel discussion on Investing in Life Sciences and Healthtech, hosted by Vantec Angel Network.

Apr 20, 2022

newsinvestment

HTuO Biosciencs closed an oversubscribed $1.5M USD angel funding round, focused on hiring key staff members, completing R&D milestones and taking their molecular modeling tool to market.

Mar 28-31, 2022

newsevent

HTuO Biosciences will be attending BIO-Europe Spring. Please contact us at info@htuobio.com to set up a partnering meeting.

Mar 10, 2022

newsevent

HTuO Biosciences participated in the Diagnostics, Digital Health and Therapeutics session at the Invest in the West conference, presented by Amplitude Ventures.

Jan 10-15, 2022

newsevent

HTuO Biosciences participated in the Bio@JPB partnering event.

Nov 4, 2021

newsevent

HTuO Biosciences participated in the Valhalla Investors Summit BC Final, presenting as one of the top five companies

Nov 3, 2021

newsevent

HTuO Biosciences presented at the 2021 LSBC Invest in BC event, sponsored by Lumira Ventures.

Oct 28, 2021

newsevent

HTuO Biosciences presented at Angel Forum Virtual Meetup

Oct 25, 2021

newsevent

Continuing our progress in the Valhalla Investors Summit BC, HTuO has been named as one of the top 5 companies, and has progressed to the final, due diligence round.

Oct 15, 2021

newsevent

After a tough round of pitches and questions at the Valhalla Investors Summit BC, HTuO Biosciences is thrilled to advance on as one of the Top 11 Startups.

Oct 1, 2021

newsevent

HTuO Biosciences has been chosen as one of the top 20 companies to join the Valhalla Investment Summit BC 2021 cohort.

Sep 24, 2021

newsevent

We are thrilled to announce that we have successfully closed the first tranche of our pre-seed round. With help from our co-lead investors VANTEC Entrepreneurs (VCC) Fund Inc., in Canada and SWAN Venture Fund, in the USA, we have received over $700,000 USD (out of $1M USD allotted for the round) from investors in Canada, the USA, and Europe. The funds will allow us to expand our team, in order to move our proof of concept to commercialization and ensure the continued operations of our business.

Sep 9, 2021

newsevent

HTuO Biosciences has been chosen to participate in the Life Sciences British Columbia Investor Readiness Program’s fall 2021 cohort.

Aug 20, 2021

news

HTuO Biosciences is pleased to announce that Dr. Judith Herzfeld, Professor Emerita and Research Professor of Chemistry at Brandeis University, will become the first member of HTuO’s Scientific Advisory Board on October 1st, 2021. Dr. Herzfeld brings a wealth of experience in molecular simulations and in the creative design of new force fields.

Aug 17, 2021

newsevent

HTuO Biosciences mentioned as one of the six companies to watch for in the Vancouver Tech Journal.

May 27, 2021

newsevent

HTuO Biosciences has been selected to present at the VANTEC Meeting: Investing in Life Sciences and HealthTech.

May 5, 2021

newsevent

HTuO Biosciences has been selected to present at the next Vantec Life Science Vantec Meeting.

Apr 8, 2021

newsawards

HTuO Biosciences shares first place at Tie Vancouver’s Demo Day along with Rehabtronics.

Mar 24, 2021

newsevent

HTuO Biosciences has been selected to present at Tie Vancouver’s Demo Day, on April 8th, 2021.

Dec 23, 2020

news

HTuO Biosciences has completed a Friends and Family Round of financing.